GlassScriptPhysician profile
Caroline Agatha Couch
NPI 1609303072
$390.08
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.96 · 2020: $16.88 · 2021: $13.17 · 2022: $171 · 2024: $28.25 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $121.41 | 2022 | |
| W. L. Gore & Associates, INC. | $92.47 | 2025 | Gore Synecor Biomaterial |
| Pacira Pharmaceuticals Incorporated | $38.00 | 2019-2021 | |
| Medtronic, INC. | $32.77 | 2022 | |
| Avanos Medical | $16.88 | 2020 | |
| Teleflex LLC | $16.59 | 2025 | Quikclot |
| Abbvie INC. | $16.58 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.06 | 2019 | |
| Ceribell, INC. | $14.52 | 2024 | Pocket Eeg Device |
| Integra Lifesciences Corporation | $13.73 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mallinckrodt Enterprises LLC | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.